NAMI
NTLA icon

Nomura Asset Management International’s Intellia Therapeutics NTLA Stock Holding History

Nomura Asset Management International’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Hold
20,000
– – ﹤0.01% 1288
2026
Q1 		$256K Hold
20,000
– – ﹤0.01% 1210
2025
Q4 		$180K Buy
+20,000
New +$275K ﹤0.01% 1228

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Nomura Asset Management International's NTLA Position: Q2 2026 in Review

Nomura Asset Management International held its Intellia Therapeutics (NTLA) position steady in Q2 2026 at 20,000 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Nomura Asset Management International first reported a position in NTLA in Q4 2025 and has held it in 3 quarters since. 326 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Nomura Asset Management International held 20,000 shares of Intellia Therapeutics worth $338K as of Q2 2026.
  • Nomura Asset Management International left its Intellia Therapeutics share count unchanged in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1288 holding.
  • Nomura Asset Management International first reported a position in Intellia Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 326 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.